Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast CancerChristopher Poole, Christopher Twelves, Sarah Bathers et al.|New England Journal of Medicine|2006Cited by 189
Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trialPeter Barrett‐Lee, Nick Murray, Angela Casbard et al.|The Lancet Oncology|2013Cited by 128